| Mar 11, 2020
Search & Destroy: Chimeric Antigen Receptor T-Cells (CAR-T)
Editor’s Note: The following article is reprinted, with permission from Biotech Primer. The original version appeared in the Biotech Primer WEEKLY. To subscribe to the Biotech Primer WEEKLY, click here. The first (and so far, only) chimeric antigen receptor T-cell (CAR-T) therapies—tisagenlecleucel and axicabtagene ciloleucel were approved in 2017, and…more.
Categories: CAR-T Cell Therapy, General